Lupin Digital Health partners with ACC to introduce DTx certificate for cardiologists

In a bid to encourage the integration of digital solutions in cardiology, ACC will grant ‘Digital Pioneer’ certificates to cardiologists who adopt Remote Cardiac Rehab and Digital Heart Failure clinic solutions

Lupin Digital Health and American College of Cardiology (ACC) have announced the introduction of digital therapeutics certificate for cardiologists.

Dr Edward Fry, the Past President of ACC, attended the event, emphasising the global significance of this collaboration in advancing cardiovascular patient care. In a bid to encourage the integration of digital solutions in cardiology, ACC will grant ‘Digital Pioneer’ certificates to cardiologists who adopt Remote Cardiac Rehab and Digital Heart Failure clinic solutions, acknowledging their commitment to innovation and patient-centered healthcare.

Expressing enthusiasm about this initiative, Rajeev Sibal, President – India Region Formulations, Lupinstated, “Lupin is proud to support cardiologists with our patient-centric solutions. As a pioneer in the DTx space, we are delighted to play a pivotal role in bringing this important ACC certificate to cardiologists and setting new standards in digital therapeutics.”

Sidharth Srinivasan, CEO, Lupin Digital Health added, “The collaboration with the American College of Cardiology marks a transformative milestone in remote cardiac rehabilitation. A growing number of doctors and cardiac institutes are acknowledging Remote Cardiac Rehab as a foundational pillar in making cardiac care more accessible. We are sure that this initiative will further encourage the healthcare fraternity to better understand and utilize technology-led Cardiac Rehab.”

Ami Bhatt, MD, ACC Chief Innovation Officer, highlighted the broader impact, “The ACC is proud to recognise cardiologists who are pioneering digital therapeutics adaptation in India through Lupin Digital Health’s Lyfe platform. This recognition underscores our commitment to advancing digital solutions that improve patient outcomes globally.”